Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Confectionery

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1942452

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1942452

Nutraceutical Gummies Market by Type (B2B, B2C), Product Type (Vitamins, Minerals, Omega-3 Fatty Acids), Consumer Type, Production Capacity, Ingredient Source, Functionality, Demographics, Sales Channel, and Region - Global Forecast to 2030

PUBLISHED:
PAGES: 529 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4%. The global nutraceutical gummies market is experiencing significant growth, driven by rising rates of vitamin deficiency and undernutrition, a growing focus on preventive health and wellness, rising consumer interest in beauty and wellness, expanding e-commerce and DTC channels, and an increasing preference for the gummy delivery format over traditional pills and capsules. Additionally, growth in plant-based and sugar-free gummies, increasing reliance of startups and D2C brands on turnkey contract manufacturing, and geographic expansion with localized formulation expertise are expected to create significant opportunities in the nutraceutical gummies market.

Scope of the Report
Years Considered for the Study2021-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million) and Volume (KT)
SegmentsType, customer type, production capacity, ingredient source, product type, functionality, demographics, sales channel, and region
Regions coveredNorth America, Europe, Asia Pacific, South America, and Rest of the World (RoW)

However, high production costs and ingredient stability issues, regulatory complexities across regions, and the complexity of maintaining batch-to-batch consistency and stability are expected to pose challenges in the nutraceutical gummies market. Furthermore, increasing audit expectations from global brand owners and intense market competition and brand differentiation also remain technical challenges.

Nutraceutical Gummies Market - IMG1

"Immunity support function is expected to hold a dominant market share during the forecast period."

The popularity of nutraceutical gummies is growing because of their convenient form, size, and ease of consumption. The benefits of multivitamin gummies for boosting immunity also play a key role in the increased demand for nutraceutical gummies. Gummies offer the fastest growth potential for vitamin and mineral supplements. The market for immunity-specific gummy supplements is expected to grow as more people become aware of how nutrition affects their health and of the specific issues that can be addressed through lifestyle factors.

"The online channel segment in the B2C segment is expected to hold a significant market share among the sales channels in the nutraceutical gummies market."

With rising awareness, demand, and traction, nutraceutical gummies have become a mainstream market staple. The increase in demand for these products has led to a rise in sales across various countries and regions, facilitated by both online and offline distribution channels. Key players are increasingly adopting and navigating their investments in distribution channels to make their products available to a wider consumer base. In addition, nutraceutical gummies manufacturing companies are promoting their products in the market through strategies such as online retailing, a part of the non-store-based distribution channel, which is expected to drive demand.

"Europe is expected to hold a significant share in the global nutraceutical gummies market during the forecast period."

Companies operating in this region are also investing in expansions and acquisitions to meet the growing demand from the dietary supplements industry, including nutraceutical gummies. The growing demand for nutraceutical gummies in Europe is attributed to fast-paced lifestyles, health-conscious consumers, and urbanization. In 2020, Unilever acquired SmartyPants Vitamins, a US-based vitamin, mineral & supplement company. SmartyPants utilizes a range of sustainably sourced, bioavailable nutrients and non-GMO-certified ingredients. Its product line is free of artificial preservatives, sweeteners, colors, and flavors. This has made Unilever expand its product portfolio and serve more consumers in Europe.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical gummies market.

  • By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
  • By Designation: CXOs - 25%, Managers - 40%, Others - 35%
  • By Region: North America - 25%, Europe - 25%, Asia Pacific - 35%, South America - 10%, and Rest of the World -5%

Prominent companies in the market include-Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestle (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature's Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US), Activ'Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US) among others.

Research Coverage

This research report categorizes the nutraceutical gummies market by type (B2B market and B2C market); customer type (B2B) (brand owners and marketing companies, retailers and distributors, healthcare and wellness providers, pharmaceutical companies, and food & beverage companies); production capacity (B2B) (small-scale contract manufacturers (< 10 m units/year), mid-scale manufacturers (10-50 m units/year), and large-scale industrial manufacturers (50 m+ units/year)); ingredient source (B2B) (animal-based source, plant-based source, microbial/fermentation-derived sources, and synthetic/chemically-derived sources); gummy base/excipients (B2B) (gelatin-based gummies, pectin-based gummies, starch-based gummies, agar, carrageenan, and other hydrocolloids); product type (B2C) (vitamins, minerals, omega-3 fatty acids, probiotics and prebiotics, collagen and beauty-from-within, herbal and botanical supplements, dietary fiber, CBD and cannabis-derived, and specialty formulations); functionality (B2C) (immunity support, general health & wellness, bone & joint health, weight management, beauty & skin health, and other functionalities); demographics (B2C) (generation alpha (0-12 years), generation Z (13-28 years), millennials (gen Y) (29-44 years), generation X (45-60 years), and baby boomers & older (61+ years)); sales channel (offline and online); and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical gummies industry. A thorough analysis of key industry players has been conducted to provide insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the nutraceutical gummies market. This report provides a competitive analysis of emerging startups in the nutraceutical gummies market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical gummies and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (increasing preference for gummy delivery format over traditional pills and capsules, driving production volume), restraints (ingredient sourcing volatility), opportunities (increasing reliance of startups and D2C brands on turnkey contract manufacturing), and challenges (increasing audit expectations from global brand owners), influencing the growth of the nutraceutical gummies market
  • Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical gummies market
  • Market Development: Comprehensive information about lucrative markets-analysis of nutraceutical gummies across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the nutraceutical gummies market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestle (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature's Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. (US), Activ'Inside (France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among other players in the nutraceutical gummies market.
Show more
Product Code: FB 10204

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 UNIT CONSIDERED
  • 1.7 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL GUMMIES MARKET
  • 2.4 HIGH GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET
  • 3.2 B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY AND REGION
  • 3.3 B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE AND REGION
  • 3.4 B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE
  • 3.5 B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE
  • 3.6 B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS
  • 3.7 B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY
  • 3.8 B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Rising rate of vitamin-deficiency diseases and undernutrition
      • 4.2.1.2 Growing consumer interest in beauty and wellness
      • 4.2.1.3 Innovation in functional formulations
      • 4.2.1.4 Growth in gummy supplement launches and custom gummy programs
      • 4.2.1.5 Increasing preference for gummy delivery format over traditional pills and capsules
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Regulatory complexities across regions
      • 4.2.2.2 Sugar content and health concerns
      • 4.2.2.3 Ingredient sourcing volatility
      • 4.2.2.4 Complexity in maintaining batch-to-batch consistency and stability
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Rising popularity of plant-based and sugar-free gummies
      • 4.2.3.2 Expansion into personalized and AI-driven nutrition
      • 4.2.3.3 Increasing reliance of startups and D2C brands on turnkey contract manufacturing
      • 4.2.3.4 Geographic expansion with localized formulation expertise
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Limited bioavailability and nutrient degradation
      • 4.2.4.2 Intense market competition and brand differentiation
      • 4.2.4.3 Logistics issues: Melting, deformation, and transit stability
      • 4.2.4.4 Increasing audit expectations from global brand owners
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMICS OUTLOOK
    • 5.2.1 INTRODUCTION
      • 5.2.1.1 Macroeconomic indicators - B2C market
        • 5.2.1.1.1 US-China trade tariff fluctuations reshape nutraceutical gummies market
        • 5.2.1.1.2 Inflation and raw material costs reshape nutraceutical gummies market
          • 5.2.1.1.2.1 Sweeteners and sugar inputs
          • 5.2.1.1.2.2 Gelling agents: Gelatin, pectin, and alternatives
          • 5.2.1.1.2.3 Vitamins, actives, flavors, and specialty additives
          • 5.2.1.1.2.4 Energy, transportation, and packaging inflation
      • 5.2.1.2 Macroeconomic indicators - B2B market
        • 5.2.1.2.1 Population aging and chronic disease burden influencing preventive health and nutraceutical market expansion
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING
    • 5.3.2 PRODUCT DEVELOPMENT AND MANUFACTURING
    • 5.3.3 QUALITY, SAFETY, AND REGULATORY COMPLIANCE
    • 5.3.4 PACKAGING & LABEL CUSTOMIZATION
    • 5.3.5 MARKETING AND DISTRIBUTION
    • 5.3.6 END USERS
  • 5.4 ECOSYSTEM ANALYSIS
    • 5.4.1 DEMAND SIDE
    • 5.4.2 SUPPLY SIDE
  • 5.5 PRICING ANALYSIS
    • 5.5.1 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER
    • 5.5.2 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION
  • 5.6 TRADE ANALYSIS
    • 5.6.1 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
    • 5.6.2 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 NESTLE HEALTH SCIENCE - EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS
    • 5.10.2 SIRIO PHARMA - EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS
    • 5.10.3 TOPGUM INDUSTRIES - EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS
    • 5.10.4 GILLCO/IFF GRINDSTED - ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN
  • 5.11 IMPACT OF 2025 US TARIFF - NUTRACEUTICAL GUMMIES MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 KEY TARIFF RATES
    • 5.11.3 PRICE IMPACT ANALYSIS
    • 5.11.4 IMPACT ON COUNTRIES/REGIONS
      • 5.11.4.1 US
      • 5.11.4.2 Europe
      • 5.11.4.3 Asia Pacific
    • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Gelling and texture technology
        • 6.1.1.1.1 Starch-based gelling technology
        • 6.1.1.1.2 Starchless gelling technology
      • 6.1.1.2 Microencapsulation technology (taste masking & flavor)
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Coating technology
      • 6.1.2.2 Nutrient stabilization methods
      • 6.1.2.3 Flavor release systems
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 3D-printing & personalized dosing platforms
      • 6.1.3.2 Plant-based and clean-label ingredient technologies
      • 6.1.3.3 Smart packaging
  • 6.2 TECHNOLOGY/PRODUCT ROADMAP
    • 6.2.1 SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION
    • 6.2.2 MID-TERM | EXPANSION & STANDARDIZATION
    • 6.2.3 LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS
  • 6.3 PATENT ANALYSIS
  • 6.4 FUTURE APPLICATIONS
    • 6.4.1 GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT
    • 6.4.2 MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES
    • 6.4.3 3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY
    • 6.4.4 EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES
    • 6.4.5 IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION
  • 6.5 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
    • 6.5.1 INTRODUCTION
    • 6.5.2 USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
    • 6.5.3 TOP USE CASES AND MARKET POTENTIAL
    • 6.5.4 BEST PRACTICES IN NUTRACEUTICAL INDUSTRY
    • 6.5.5 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET
    • 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.5.7 CLIENTS' READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
    • 7.1.3 LABELING REQUIREMENTS AND CLAIMS
    • 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
      • 7.1.4.1 Mandatory validation of bioavailability & functional claims
      • 7.1.4.2 Global harmonization of dietary supplement & nutraceutical classifications
      • 7.1.4.3 Strengthened safety, contaminant, & additive control regulations
      • 7.1.4.4 Digital labeling, traceability & QR-based compliance tracking
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 SUSTAINABLE SOURCING
    • 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
    • 7.2.3 CIRCULAR ECONOMY APPROACHES
  • 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • 8.5 MARKET PROFITABILITY
  • 8.6 REVENUE POTENTIAL
    • 8.6.1 COST DYNAMICS
    • 8.6.2 MARGIN OPPORTUNITIES, BY TYPE

9 NUTRACEUTICAL GUMMIES MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 B2C MARKET
    • 9.2.1 ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES
  • 9.3 B2B MARKET
    • 9.3.1 POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS

10 NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE

  • 10.1 INTRODUCTION
  • 10.2 BRAND OWNERS & MARKETING COMPANIES
    • 10.2.1 DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS
  • 10.3 RETAILERS & DISTRIBUTORS
    • 10.3.1 RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS
  • 10.4 HEALTHCARE & WELLNESS
    • 10.4.1 GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS
  • 10.5 PHARMACEUTICAL COMPANIES
    • 10.5.1 PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION
  • 10.6 FOOD & BEVERAGE COMPANIES
    • 10.6.1 CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES

11 NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY

  • 11.1 INTRODUCTION
  • 11.2 SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR)
    • 11.2.1 GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS
  • 11.3 MID-SCALE MANUFACTURERS (10-50 M UNITS/YEAR)
    • 11.3.1 INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION
  • 11.4 LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR)
    • 11.4.1 RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS

12 NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE

  • 12.1 INTRODUCTION
  • 12.2 ANIMAL-BASED SOURCES
    • 12.2.1 COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT
  • 12.3 PLANT-BASED SOURCES
    • 12.3.1 VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION
  • 12.4 MICROBIAL/FERMENTATION-DERIVED SOURCES
    • 12.4.1 ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS
  • 12.5 SYNTHETIC/CHEMICALLY-DERIVED SOURCES
    • 12.5.1 CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE

13 NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS

  • 13.1 INTRODUCTION
  • 13.2 GELATIN-BASED GUMMIES
    • 13.2.1 HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE
  • 13.3 PECTIN-BASED GUMMIES
    • 13.3.1 VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION
  • 13.4 STARCH-BASED GUMMIES
    • 13.4.1 COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS
  • 13.5 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS

14 NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE

  • 14.1 INTRODUCTION
  • 14.2 VITAMINS
    • 14.2.1 RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT
    • 14.2.2 MULTIVITAMINS
    • 14.2.3 VITAMIN C
    • 14.2.4 VITAMIN D
    • 14.2.5 VITAMIN B COMPLEX
    • 14.2.6 VITAMIN E AND A
  • 14.3 MINERALS
    • 14.3.1 MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT
    • 14.3.2 CALCIUM
    • 14.3.3 IRON
    • 14.3.4 ZINC
    • 14.3.5 MAGNESIUM
  • 14.4 OMEGA-3 FATTY ACIDS
  • 14.5 PROBIOTICS & PREBIOTICS
    • 14.5.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
  • 14.6 COLLAGEN & BEAUTY-FROM-WITHIN
    • 14.6.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
  • 14.7 HERBAL & BOTANICAL
    • 14.7.1 RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT
    • 14.7.2 ASHWAGANDHA
    • 14.7.3 TURMERIC/CURCUMIN
    • 14.7.4 ELDERBERRY
    • 14.7.5 MELATONIN
    • 14.7.6 OTHER HERBAL AND BOTANICAL GUMMIES
  • 14.8 DIETARY FIBER
  • 14.9 CBD & CANNABIS-DERIVED
  • 14.10 SPECIALTY FORMULATIONS
    • 14.10.1 HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH

15 NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY

  • 15.1 INTRODUCTION
  • 15.2 IMMUNITY SUPPORT
    • 15.2.1 RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET
  • 15.3 GENERAL HEALTH & WELLNESS
    • 15.3.1 GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET
  • 15.4 BONE & JOINT HEALTH
    • 15.4.1 RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH
  • 15.5 WEIGHT MANAGEMENT
    • 15.5.1 RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET
  • 15.6 BEAUTY & SKIN HEALTH
    • 15.6.1 INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET

16 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS

  • 16.1 INTRODUCTION
  • 16.2 GENERATION ALPHA (0-12 YEARS)
    • 16.2.1 EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES
  • 16.3 GENERATION Z (13-28 YEARS)
    • 16.3.1 FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND
  • 16.4 MILLENNIALS (GEN Y) (29-44 YEARS)
    • 16.4.1 LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION
  • 16.5 GENERATION X (45-60 YEARS)
    • 16.5.1 WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET
  • 16.6 BABY BOOMERS AND OLDER (61+ YEARS)
    • 16.6.1 HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE

17 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL

  • 17.1 INTRODUCTION
  • 17.2 OFFLINE CHANNELS
    • 17.2.1 HYPERMARKETS & SUPERMARKETS
      • 17.2.1.1 Preferred purchasing destination and availability of variants to drive growth
    • 17.2.2 PHARMACIES & DRUGSTORES
      • 17.2.2.1 Wide presence and around-the-clock services to drive growth
    • 17.2.3 SPECIALTY HEALTH STORES
      • 17.2.3.1 Enabling premium and targeted gummy supplement sales
    • 17.2.4 CONVENIENCE STORES
      • 17.2.4.1 Preference toward specialized healthcare products to fuel growth
    • 17.2.5 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM)
      • 17.2.5.1 High-volume retail and network-based selling drive offline expansion
  • 17.3 ONLINE CHANNELS

18 NUTRACEUTICAL GUMMIES MARKET, BY REGION

  • 18.1 INTRODUCTION
  • 18.2 NORTH AMERICA
    • 18.2.1 US
      • 18.2.1.1 Presence of key players and various health trends to boost market
    • 18.2.2 CANADA
      • 18.2.2.1 Convenience, taste, and health benefits to drive demand for nutraceutical gummies
    • 18.2.3 MEXICO
      • 18.2.3.1 Rising health-conscious and vegan population to drive market
  • 18.3 EUROPE
    • 18.3.1 GERMANY
      • 18.3.1.1 Growing interest in health & wellness to drive market
    • 18.3.2 UK
      • 18.3.2.1 Rising prevalence of diseases to drive market
    • 18.3.3 FRANCE
      • 18.3.3.1 High healthcare costs and increased demand for dietary supplements to drive market
    • 18.3.4 SPAIN
      • 18.3.4.1 Adoption of healthy lifestyles to drive market
    • 18.3.5 ITALY
      • 18.3.5.1 Strong e-commerce system and rising geriatric population to drive market
    • 18.3.6 REST OF EUROPE
  • 18.4 ASIA PACIFIC
    • 18.4.1 CHINA
      • 18.4.1.1 Large population and increasing prevalence of diseases to drive market
    • 18.4.2 JAPAN
      • 18.4.2.1 Rising awareness and shifting preferences toward dietary supplements to drive market
    • 18.4.3 INDIA
      • 18.4.3.1 Rising disposable incomes and growing focus on wellness to drive market
    • 18.4.4 AUSTRALIA & NEW ZEALAND
      • 18.4.4.1 High demand for dietary supplements, particularly in new formats, to drive market
    • 18.4.5 REST OF ASIA PACIFIC
  • 18.5 SOUTH AMERICA
    • 18.5.1 BRAZIL
      • 18.5.1.1 Increasing consumer preference for convenient and palatable formats in nutrient intake to drive market
    • 18.5.2 ARGENTINA
      • 18.5.2.1 Growing focus on prevention of micronutrient deficiencies and cardiometabolic risks to drive market
    • 18.5.3 REST OF SOUTH AMERICA
  • 18.6 REST OF THE WORLD
    • 18.6.1 MIDDLE EAST
      • 18.6.1.1 Rising disposable incomes and healthcare costs to drive market
    • 18.6.2 AFRICA
      • 18.6.2.1 Increase in vitamin deficiency and consumer awareness about health supplements to fuel market

19 COMPETITIVE LANDSCAPE

  • 19.1 OVERVIEW
  • 19.2 B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020-2025
  • 19.3 REVENUE ANALYSIS (B2C MARKET), 2022-2024
  • 19.4 MARKET SHARE ANALYSIS (B2C MARKET), 2024
  • 19.5 MARKET SHARE ANALYSIS (B2B MARKET), 2024
  • 19.6 BRAND/PRODUCT COMPARISON
  • 19.7 COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024
    • 19.7.1 STARS
    • 19.7.2 EMERGING LEADERS
    • 19.7.3 PERVASIVE PLAYERS
    • 19.7.4 PARTICIPANTS
    • 19.7.5 COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024
      • 19.7.5.1 Company footprint
      • 19.7.5.2 Regional footprint
      • 19.7.5.3 Product type footprint
      • 19.7.5.4 Functionality footprint
  • 19.8 COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024
    • 19.8.1 STARS
    • 19.8.2 EMERGING LEADERS
    • 19.8.3 PERVASIVE PLAYERS
    • 19.8.4 PARTICIPANTS
    • 19.8.5 COMPETITIVE BENCHMARKING
      • 19.8.5.1 Detailed list of B2B key players
    • 19.8.6 COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024
      • 19.8.6.1 Competitive benchmarking of key B2B companies
  • 19.9 COMPANY VALUATION AND FINANCIAL METRICS
  • 19.10 COMPETITIVE SCENARIO
    • 19.10.1 PRODUCT LAUNCHES
    • 19.10.2 DEALS
    • 19.10.3 EXPANSIONS
    • 19.10.4 OTHER DEVELOPMENTS

20 COMPANY PROFILES

  • 20.1 B2C PLAYERS (BRAND MANUFACTURERS)
    • 20.1.1 CHURCH & DWIGHT CO., INC.
      • 20.1.1.1 Business overview
      • 20.1.1.2 Products/Solutions/Services offered
      • 20.1.1.3 Recent developments
        • 20.1.1.3.1 Product launches
      • 20.1.1.4 MnM view
        • 20.1.1.4.1 Key strengths
        • 20.1.1.4.2 Strategic choices
        • 20.1.1.4.3 Weaknesses and competitive threats
    • 20.1.2 H&H GROUP
      • 20.1.2.1 Business overview
      • 20.1.2.2 Products/Solutions/Services offered
      • 20.1.2.3 Recent developments
        • 20.1.2.3.1 Deals
        • 20.1.2.3.2 Expansions
        • 20.1.2.3.3 Other developments
      • 20.1.2.4 MnM view
        • 20.1.2.4.1 Key strengths
        • 20.1.2.4.2 Strategic choices
        • 20.1.2.4.3 Weaknesses and competitive threats
    • 20.1.3 AMWAY
      • 20.1.3.1 Business overview
      • 20.1.3.2 Products/Solutions/Services offered
      • 20.1.3.3 Recent developments
        • 20.1.3.3.1 Product launches
        • 20.1.3.3.2 Deals
      • 20.1.3.4 MnM view
        • 20.1.3.4.1 Key strengths
        • 20.1.3.4.2 Strategic choices
        • 20.1.3.4.3 Weaknesses and competitive threats
    • 20.1.4 BAYER AG
      • 20.1.4.1 Business overview
      • 20.1.4.2 Products/Solutions/Services offered
      • 20.1.4.3 Recent developments
        • 20.1.4.3.1 Product launches
      • 20.1.4.4 MnM view
        • 20.1.4.4.1 Key strengths
        • 20.1.4.4.2 Strategic choices
        • 20.1.4.4.3 Weaknesses and competitive threats
    • 20.1.5 HALEON GROUP OF COMPANIES
      • 20.1.5.1 Business overview
      • 20.1.5.2 Products/Solutions/Services offered
      • 20.1.5.3 Recent developments
        • 20.1.5.3.1 Product launches
        • 20.1.5.3.2 Deals
        • 20.1.5.3.3 Expansions
      • 20.1.5.4 MnM view
        • 20.1.5.4.1 Key strengths
        • 20.1.5.4.2 Strategic choices
        • 20.1.5.4.3 Weaknesses and competitive threats
    • 20.1.6 NESTLE
      • 20.1.6.1 Business overview
      • 20.1.6.2 Products/Solutions/Services offered
      • 20.1.6.3 Recent developments
        • 20.1.6.3.1 Product launches
        • 20.1.6.3.2 Deals
      • 20.1.6.4 MnM view
        • 20.1.6.4.1 Key strengths
        • 20.1.6.4.2 Strategic choices
        • 20.1.6.4.3 Weaknesses and competitive threats
    • 20.1.7 UNILEVER
      • 20.1.7.1 Business overview
      • 20.1.7.2 Products/Solutions/Services offered
      • 20.1.7.3 Recent developments
        • 20.1.7.3.1 Product launches
        • 20.1.7.3.2 Deals
        • 20.1.7.3.3 Expansions
      • 20.1.7.4 MnM view
        • 20.1.7.4.1 Key strengths
        • 20.1.7.4.2 Strategic choices
        • 20.1.7.4.3 Weaknesses and competitive threats
    • 20.1.8 OTSUKA HOLDINGS CO., LTD.
      • 20.1.8.1 Business overview
      • 20.1.8.2 Products/Solutions/Services offered
      • 20.1.8.3 Recent developments
        • 20.1.8.3.1 Product launches
        • 20.1.8.3.2 Expansions
      • 20.1.8.4 MnM view
        • 20.1.8.4.1 Key strengths
        • 20.1.8.4.2 Strategic choices
        • 20.1.8.4.3 Weaknesses and competitive threats
    • 20.1.9 PHARMACARE LABORATORIES
      • 20.1.9.1 Business overview
      • 20.1.9.2 Products/Solutions/Services offered
      • 20.1.9.3 Recent developments
        • 20.1.9.3.1 Expansions
      • 20.1.9.4 MnM view
    • 20.1.10 SWANSON
      • 20.1.10.1 Business overview
      • 20.1.10.2 Products/Solutions/Services offered
      • 20.1.10.3 Recent developments
        • 20.1.10.3.1 Product launches
      • 20.1.10.4 MnM view
    • 20.1.11 IM HEALTHCARE
      • 20.1.11.1 Business overview
      • 20.1.11.2 Products/Solutions/Services offered
      • 20.1.11.3 Recent developments
      • 20.1.11.4 MnM view
    • 20.1.12 SMP NUTRA
      • 20.1.12.1 Business overview
      • 20.1.12.2 Products/Solutions/Services offered
      • 20.1.12.3 Recent developments
      • 20.1.12.4 MnM view
    • 20.1.13 NATURE'S TRUTH
      • 20.1.13.1 Business overview
      • 20.1.13.2 Products/Solutions/Services offered
      • 20.1.13.3 Recent developments
        • 20.1.13.3.1 Other developments
      • 20.1.13.4 MnM view
    • 20.1.14 HERBALAND NATURALS INC.
      • 20.1.14.1 Business overview
      • 20.1.14.2 Products/Solutions/Services offered
      • 20.1.14.3 Recent developments
      • 20.1.14.4 MnM view
    • 20.1.15 BOSCOGEN, INC.
      • 20.1.15.1 Business overview
      • 20.1.15.2 Products/Solutions/Services offered
      • 20.1.15.3 Recent developments
      • 20.1.15.4 MnM view
  • 20.2 B2B PLAYERS (CONTRACT MANUFACTURERS)
    • 20.2.1 SOFGEN PHARMA
      • 20.2.1.1 Business overview
      • 20.2.1.2 Products/Services/Solutions offered
      • 20.2.1.3 Recent developments
        • 20.2.1.3.1 Expansions
      • 20.2.1.4 MnM view
        • 20.2.1.4.1 Key strengths
        • 20.2.1.4.2 Strategic choices
        • 20.2.1.4.3 Weaknesses & competitive threats
    • 20.2.2 CATALENT, INC.
      • 20.2.2.1 Business overview
      • 20.2.2.2 Products/Services/Solutions offered
      • 20.2.2.3 Recent developments
        • 20.2.2.3.1 Deals
      • 20.2.2.4 MnM view
        • 20.2.2.4.1 Key strengths
        • 20.2.2.4.2 Strategic choices
        • 20.2.2.4.3 Weaknesses & competitive threats
    • 20.2.3 ACTIV'INSIDE
      • 20.2.3.1 Business overview
      • 20.2.3.2 Products/Services/Solutions offered
      • 20.2.3.3 Recent developments
      • 20.2.3.4 MnM view
        • 20.2.3.4.1 Key strengths
        • 20.2.3.4.2 Strategic choices
        • 20.2.3.4.3 Weaknesses & competitive threats
    • 20.2.4 SIRIO PHARMA CO., LTD.
      • 20.2.4.1 Business overview
      • 20.2.4.2 Products/Services/Solutions offered
      • 20.2.4.3 Recent developments
        • 20.2.4.3.1 Product launches
      • 20.2.4.4 MnM view
    • 20.2.5 WIN NUTRA
      • 20.2.5.1 Business overview
      • 20.2.5.2 Products/Services/Solutions offered
      • 20.2.5.3 Recent developments
      • 20.2.5.4 MnM view
    • 20.2.6 MAKERS NUTRITION, LLC
      • 20.2.6.1 Business overview
      • 20.2.6.2 Products/Services/Solutions offered
      • 20.2.6.3 Recent developments
      • 20.2.6.4 MnM view
    • 20.2.7 ION LABS
      • 20.2.7.1 Business overview
      • 20.2.7.2 Products/Services/Solutions offered
      • 20.2.7.3 Recent developments
        • 20.2.7.3.1 Expansions
        • 20.2.7.3.2 Deals
      • 20.2.7.4 MnM view
    • 20.2.8 VITAJOY GROUP
      • 20.2.8.1 Business overview
      • 20.2.8.2 Products/Services/Solutions offered
      • 20.2.8.3 Recent developments
      • 20.2.8.4 MnM view
    • 20.2.9 BLISS LIFESCIENCES LLP
      • 20.2.9.1 Business overview
      • 20.2.9.2 Products/Services/Solutions offered
      • 20.2.9.3 Recent developments
      • 20.2.9.4 MnM view
    • 20.2.10 GLOBAL WIDGET
      • 20.2.10.1 Business overview
      • 20.2.10.2 Products/Services/Solutions offered
      • 20.2.10.3 Recent developments
        • 20.2.10.3.1 Product launches
        • 20.2.10.3.2 Deals
        • 20.2.10.3.3 Expansions
      • 20.2.10.4 MnM view
    • 20.2.11 GUMMY WORLDS
    • 20.2.12 TOPGUM
    • 20.2.13 MERICAL
    • 20.2.14 FERMENTIS LIFE SCIENCES
    • 20.2.15 EAGLE LABS, INC.

21 RESEARCH METHODOLOGY

  • 21.1 RESEARCH DATA
    • 21.1.1 SECONDARY DATA
      • 21.1.1.1 Key data from secondary sources
    • 21.1.2 PRIMARY DATA
      • 21.1.2.1 Key industry insights
      • 21.1.2.2 Breakdown of primary interviews
      • 21.1.2.3 Primary sources
  • 21.2 MARKET SIZE ESTIMATION
    • 21.2.1 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE
    • 21.2.2 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE
    • 21.2.3 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 21.2.4 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • 21.3 DATA TRIANGULATION
  • 21.4 RESEARCH ASSUMPTIONS
  • 21.5 RESEARCH LIMITATIONS

22 ADJACENT & RELATED MARKETS

  • 22.1 INTRODUCTION
  • 22.2 LIMITATIONS
  • 22.3 NUTRACEUTICAL INGREDIENTS MARKET
    • 22.3.1 MARKET DEFINITION
    • 22.3.2 MARKET OVERVIEW
  • 22.4 DIETARY SUPPLEMENTS MARKET
    • 22.4.1 MARKET DEFINITION
    • 22.4.2 MARKET OVERVIEW

23 APPENDIX

  • 23.1 DISCUSSION GUIDE
  • 23.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 23.3 CUSTOMIZATION OPTIONS
  • 23.4 RELATED REPORTS
  • 23.5 AUTHOR DETAILS
Show more
Product Code: FB 10204

List of Tables

  • TABLE 1 USD EXCHANGE RATES, 2020-2024
  • TABLE 2 IMPACT OF PORTER'S FIVE FORCES NUTRACEUTICAL GUMMIES MARKET
  • TABLE 3 NUTRACEUTICAL GUMMIES MARKET: SUPPLY CHAIN (ECOSYSTEM)
  • TABLE 4 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER, 2023 (USD/UNIT)
  • TABLE 5 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021-2024 (USD/TON)
  • TABLE 6 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2024
  • TABLE 7 IMPORT AND EXPORT SCENARIO FOR HS CODE: 210690, BY COUNTRY, 2023
  • TABLE 8 NUTRACEUTICAL GUMMIES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 9 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 10 PATENTS PERTAINING TO NUTRACEUTICAL GUMMIES, 2019-2025
  • TABLE 11 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 12 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 13 NUTRACEUTICAL GUMMIES MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 14 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 GLOBAL INDUSTRY STANDARDS IN NUTRACEUTICAL GUMMIES MARKET
  • TABLE 21 LABELING REQUIREMENTS AND CLAIMS IN NUTRACEUTICAL GUMMIES MARKET
  • TABLE 22 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN NUTRACEUTICAL GUMMIES MARKET
  • TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES
  • TABLE 24 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • TABLE 25 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET, BY KEY INDUSTRIES ACROSS SUPPLY CHAIN
  • TABLE 26 COST DYNAMICS IN NUTRACEUTICAL GUMMIES MARKET
  • TABLE 27 MARGIN OPPORTUNITIES IN NUTRACEUTICAL GUMMIES MARKET, BY TYPE
  • TABLE 28 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 29 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 30 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (TONS)
  • TABLE 31 NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (TONS)
  • TABLE 32 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 33 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 34 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 35 BRAND OWNERS & MARKETING COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 36 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 37 RETAILERS & DISTRIBUTORS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 38 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 39 HEALTHCARE & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 40 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 41 PHARMACEUTICAL COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 42 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 43 FOOD & BEVERAGE COMPANIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 44 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 45 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 46 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 47 SMALL-SCALE CONTRACT MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 48 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 49 MID-SCALE MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 50 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 51 LARGE-SCALE INDUSTRIAL MANUFACTURERS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 52 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 53 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 54 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 55 ANIMAL-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 56 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 57 PLANT-BASED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 58 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 59 MICROBIAL/FERMENTATION-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 60 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 61 SYNTHETIC/CHEMICALLY-DERIVED SOURCES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 62 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 63 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 64 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 65 GELATIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 66 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 67 PECTIN-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 68 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 69 STARCH-BASED GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 70 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 71 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 72 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 73 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 74 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 75 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 76 VITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 77 VITAMIN GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 78 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 79 MULTIVITAMINS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 80 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 81 VITAMIN C: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 82 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 83 VITAMIN D: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 84 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 85 VITAMIN B COMPLEX: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 86 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 87 VITAMIN E & A: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 88 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 89 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 90 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 91 MINERALS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 92 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 93 CALCIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 94 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 95 IRON: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 96 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 97 ZINC: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 98 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 99 MAGNESIUM: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 100 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 101 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 102 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 103 PROBIOTICS & PREBIOTICS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 104 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 105 COLLAGEN & BEAUTY-FROM-WITHIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 106 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 107 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 108 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 109 HERBAL & BOTANICAL: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 110 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 111 ASHWAGANDHA: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 112 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 113 TURMERIC/CURCUMIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 114 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 115 ELDERBERRY: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 116 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 117 MELATONIN: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 118 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 119 OTHER HERBAL AND BOTANICAL GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 120 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 121 DIETARY FIBER: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 122 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 123 CBD & CANNABIS-DERIVED: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 124 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 125 SPECIALTY FORMULATIONS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 126 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 127 NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 128 IMMUNITY SUPPORT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 129 IMMUNITY SUPPORT GUMMIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 130 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 131 GENERAL HEALTH & WELLNESS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 132 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 133 BONE & JOINT HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 134 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 135 WEIGHT MANAGEMENT: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 136 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 137 BEAUTY & SKIN HEALTH: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 138 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 139 OTHER FUNCTIONALITIES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 140 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 141 NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 142 GENERATION ALPHA (0-12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 143 GENERATION ALPHA (0-12 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 144 GENERATION Z (13-28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 145 GENERATION Z (13-28 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 146 MILLENNIALS (29-44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 147 MILLENNIALS (29-44 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 148 GENERATION X (45-60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 149 GENERATION X (45-60 YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 150 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 151 BABY BOOMERS AND OLDER (61+ YEARS): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 152 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 153 NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 154 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 155 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 156 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 157 OFFLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 158 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 159 HYPERMARKETS & SUPERMARKETS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 160 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 161 PHARMACIES & DRUG STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 162 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 163 SPECIALTY HEALTH STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 164 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 165 CONVENIENCE STORES: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 166 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 167 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM): NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 168 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 169 ONLINE CHANNELS: NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 170 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 171 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 172 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (TONS)
  • TABLE 173 B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (TONS)
  • TABLE 174 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 175 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 176 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (TONS)
  • TABLE 177 B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (TONS)
  • TABLE 178 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 179 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 181 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 182 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 183 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 185 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 186 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 187 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 188 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (TONS)
  • TABLE 189 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (TONS)
  • TABLE 190 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 191 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 192 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (TONS)
  • TABLE 193 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (TONS)
  • TABLE 194 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 195 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 196 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (TONS)
  • TABLE 197 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (TONS)
  • TABLE 198 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 199 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 200 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (TONS)
  • TABLE 201 NORTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (TONS)
  • TABLE 202 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 203 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 204 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (TONS)
  • TABLE 205 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (TONS)
  • TABLE 206 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (USD MILLION)
  • TABLE 207 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (USD MILLION)
  • TABLE 208 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (TONS)
  • TABLE 209 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (TONS)
  • TABLE 210 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (USD MILLION)
  • TABLE 211 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (USD MILLION)
  • TABLE 212 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (TONS)
  • TABLE 213 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (TONS)
  • TABLE 214 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (USD MILLION)
  • TABLE 215 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (USD MILLION)
  • TABLE 216 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (TONS)
  • TABLE 217 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (TONS)
  • TABLE 218 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 219 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 220 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 221 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 222 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 223 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 224 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 225 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 226 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 227 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 228 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (TONS)
  • TABLE 229 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (TONS)
  • TABLE 230 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 231 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 232 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (TONS)
  • TABLE 233 NORTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (TONS)
  • TABLE 234 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 235 US: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 236 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 237 US: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 238 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 239 CANADA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 240 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 241 CANADA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 242 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 243 MEXICO: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 244 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 245 MEXICO: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 246 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 247 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 248 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 249 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 250 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 251 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 252 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 253 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 254 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 255 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 256 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (TONS)
  • TABLE 257 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (TONS)
  • TABLE 258 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 259 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 260 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (TONS)
  • TABLE 261 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (TONS)
  • TABLE 262 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 263 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 264 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (TONS)
  • TABLE 265 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (TONS)
  • TABLE 266 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 267 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 268 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (TONS)
  • TABLE 269 EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (TONS)
  • TABLE 270 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 271 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 272 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (TONS)
  • TABLE 273 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (TONS)
  • TABLE 274 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (USD MILLION)
  • TABLE 275 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (USD MILLION)
  • TABLE 276 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (TONS)
  • TABLE 277 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (TONS)
  • TABLE 278 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (USD MILLION)
  • TABLE 279 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (USD MILLION)
  • TABLE 280 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (TONS)
  • TABLE 281 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (TONS)
  • TABLE 282 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (USD MILLION)
  • TABLE 283 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (USD MILLION)
  • TABLE 284 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (TONS)
  • TABLE 285 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (TONS)
  • TABLE 286 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 287 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 288 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 289 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 290 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 291 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 292 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 293 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 294 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 295 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 296 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (TONS)
  • TABLE 297 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (TONS)
  • TABLE 298 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 299 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 300 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (TONS)
  • TABLE 301 EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (TONS)
  • TABLE 302 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 303 GERMANY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 304 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 305 GERMANY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 306 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 307 UK: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 308 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 309 UK: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 310 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 311 FRANCE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 312 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 313 FRANCE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 314 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 315 SPAIN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 316 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 317 SPAIN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 318 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 319 ITALY: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 320 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 321 ITALY: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 322 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 323 REST OF EUROPE: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 324 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 325 REST OF EUROPE: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 326 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 327 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 329 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 330 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 331 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 332 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 333 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 334 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 335 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (TONS)
  • TABLE 337 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (TONS)
  • TABLE 338 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 339 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 340 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (TONS)
  • TABLE 341 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (TONS)
  • TABLE 342 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 343 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (TONS)
  • TABLE 345 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (TONS)
  • TABLE 346 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (TONS)
  • TABLE 349 ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (TONS)
  • TABLE 350 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (TONS)
  • TABLE 353 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (TONS)
  • TABLE 354 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (USD MILLION)
  • TABLE 355 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (USD MILLION)
  • TABLE 356 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (TONS)
  • TABLE 357 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (TONS)
  • TABLE 358 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (USD MILLION)
  • TABLE 359 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (USD MILLION)
  • TABLE 360 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (TONS)
  • TABLE 361 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (TONS)
  • TABLE 362 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (USD MILLION)
  • TABLE 363 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (USD MILLION)
  • TABLE 364 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (TONS)
  • TABLE 365 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (TONS)
  • TABLE 366 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 367 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 368 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 369 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 370 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 371 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 372 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 373 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 374 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 375 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 376 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (TONS)
  • TABLE 377 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (TONS)
  • TABLE 378 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 380 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (TONS)
  • TABLE 381 ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (TONS)
  • TABLE 382 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 383 CHINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 384 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 385 CHINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 386 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 387 JAPAN: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 388 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 389 JAPAN: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 390 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 391 INDIA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 392 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 393 INDIA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 394 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 395 AUSTRALIA & NEW ZEALAND: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 396 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 397 AUSTRALIA & NEW ZEALAND: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 398 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 399 REST OF ASIA PACIFIC: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 400 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 401 REST OF ASIA PACIFIC: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 402 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 403 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 404 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 405 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 406 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 407 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 408 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2021-2024 (TONS)
  • TABLE 409 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY, 2025-2030 (TONS)
  • TABLE 410 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 411 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 412 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (TONS)
  • TABLE 413 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (TONS)
  • TABLE 414 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 415 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 416 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (TONS)
  • TABLE 417 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (TONS)
  • TABLE 418 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 419 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 420 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (TONS)
  • TABLE 421 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (TONS)
  • TABLE 422 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 423 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 424 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (TONS)
  • TABLE 425 SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (TONS)
  • TABLE 426 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 427 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 428 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (TONS)
  • TABLE 429 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (TONS)
  • TABLE 430 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (USD MILLION)
  • TABLE 431 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (USD MILLION)
  • TABLE 432 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (TONS)
  • TABLE 433 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (TONS)
  • TABLE 434 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (USD MILLION)
  • TABLE 435 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (USD MILLION)
  • TABLE 436 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (TONS)
  • TABLE 437 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (TONS)
  • TABLE 438 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (USD MILLION)
  • TABLE 439 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (USD MILLION)
  • TABLE 440 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (TONS)
  • TABLE 441 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (TONS)
  • TABLE 442 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 443 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 444 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 445 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 446 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 447 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 448 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 449 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 450 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 451 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 452 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (TONS)
  • TABLE 453 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (TONS)
  • TABLE 454 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 455 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 456 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (TONS)
  • TABLE 457 SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (TONS)
  • TABLE 458 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 459 BRAZIL: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 460 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 461 BRAZIL: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 462 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 463 ARGENTINA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 464 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 465 ARGENTINA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 466 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 467 REST OF SOUTH AMERICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 468 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 469 REST OF SOUTH AMERICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 470 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 471 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 472 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (TONS)
  • TABLE 473 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (TONS)
  • TABLE 474 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 475 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 476 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2021-2024 (TONS)
  • TABLE 477 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY REGION, 2025-2030 (TONS)
  • TABLE 478 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (USD MILLION)
  • TABLE 479 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (USD MILLION)
  • TABLE 480 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2021-2024 (TONS)
  • TABLE 481 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025-2030 (TONS)
  • TABLE 482 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 483 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 484 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (TONS)
  • TABLE 485 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (TONS)
  • TABLE 486 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (USD MILLION)
  • TABLE 487 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (USD MILLION)
  • TABLE 488 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2021-2024 (TONS)
  • TABLE 489 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025-2030 (TONS)
  • TABLE 490 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (USD MILLION)
  • TABLE 491 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (USD MILLION)
  • TABLE 492 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2021-2024 (TONS)
  • TABLE 493 REST OF THE WORLD: B2B NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025-2030 (TONS)
  • TABLE 494 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 495 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 496 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (TONS)
  • TABLE 497 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (TONS)
  • TABLE 498 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (USD MILLION)
  • TABLE 499 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (USD MILLION)
  • TABLE 500 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2021-2024 (TONS)
  • TABLE 501 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY VITAMIN, 2025-2030 (TONS)
  • TABLE 502 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (USD MILLION)
  • TABLE 503 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (USD MILLION)
  • TABLE 504 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2021-2024 (TONS)
  • TABLE 505 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY HERBAL & BOTANICAL, 2025-2030 (TONS)
  • TABLE 506 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (USD MILLION)
  • TABLE 507 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (USD MILLION)
  • TABLE 508 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2021-2024 (TONS)
  • TABLE 509 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY MINERAL, 2025-2030 (TONS)
  • TABLE 510 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 511 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 512 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 513 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 514 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (USD MILLION)
  • TABLE 515 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 516 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2021-2024 (TONS)
  • TABLE 517 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY OFFLINE DISTRIBUTION CHANNEL, 2025-2030 (TONS)
  • TABLE 518 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (USD MILLION)
  • TABLE 519 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (USD MILLION)
  • TABLE 520 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2021-2024 (TONS)
  • TABLE 521 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS, 2025-2030 (TONS)
  • TABLE 522 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (USD MILLION)
  • TABLE 523 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 524 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2021-2024 (TONS)
  • TABLE 525 REST OF THE WORLD: B2C NUTRACEUTICAL GUMMIES MARKET, BY FUNCTIONALITY, 2025-2030 (TONS)
  • TABLE 526 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 527 MIDDLE EAST: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 528 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 529 MIDDLE EAST: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 530 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2021-2024 (USD MILLION)
  • TABLE 531 AFRICA: B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
  • TABLE 532 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2021-2024 (USD MILLION)
  • TABLE 533 AFRICA: B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 534 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL GUMMIES MARKET, 2020-2025
  • TABLE 535 B2C NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 536 B2B NUTRACEUTICAL GUMMIES MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 537 B2C NUTRACEUTICAL GUMMIES MARKET: REGIONAL FOOTPRINT
  • TABLE 538 B2C NUTRACEUTICAL GUMMIES MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 539 B2C NUTRACEUTICAL GUMMIES MARKET: FUNCTIONALITY FOOTPRINT
  • TABLE 541 NUTRACEUTICAL GUMMIES MARKET: COMPETITIVE BENCHMARKING OF B2B COMPANIES
  • TABLE 542 NUTRACEUTICAL GUMMIES MARKET: PRODUCT LAUNCHES, 2020- OCTOBER 2025
  • TABLE 543 NUTRACEUTICAL GUMMIES MARKET: DEALS, 2020-OCTOBER 2025
  • TABLE 544 NUTRACEUTICAL GUMMIES MARKET: EXPANSIONS, 2020-OCTOBER 2025
  • TABLE 545 NUTRACEUTICAL GUMMIES MARKET: OTHER DEVELOPMENTS, 2020- OCTOBER 2025
  • TABLE 546 CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW
  • TABLE 547 CHURCH & DWIGHT CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 548 CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES
  • TABLE 549 H&H GROUP: COMPANY OVERVIEW
  • TABLE 550 H&H GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 551 H&H GROUP: DEALS
  • TABLE 552 H&H GROUP: EXPANSIONS
  • TABLE 553 H&H GROUP: OTHER DEVELOPMENTS
  • TABLE 554 AMWAY: COMPANY OVERVIEW
  • TABLE 555 AMWAY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 556 AMWAY: PRODUCT LAUNCHES
  • TABLE 557 AMWAY: DEALS
  • TABLE 558 BAYER AG: COMPANY OVERVIEW
  • TABLE 559 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 560 BAYER AG: PRODUCT LAUNCHES
  • TABLE 561 HALEON GROUP OF COMPANIES: COMPANY OVERVIEW
  • TABLE 562 HALEON GROUP OF COMPANIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 563 HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES
  • TABLE 564 HALEON GROUP OF COMPANIES: DEALS
  • TABLE 565 HALEON GROUP OF COMPANIES: EXPANSIONS
  • TABLE 566 NESTLE: COMPANY OVERVIEW
  • TABLE 567 NESTLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 568 NESTLE: PRODUCT LAUNCHES
  • TABLE 569 NESTLE: DEALS
  • TABLE 570 UNILEVER: COMPANY OVERVIEW
  • TABLE 571 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 572 UNILEVER: PRODUCT LAUNCHES
  • TABLE 573 UNILEVER: DEALS
  • TABLE 574 UNILEVER: EXPANSIONS
  • TABLE 575 OTSUKA HOLDINGS CO., LTD.: COMPANY OVERVIEW
  • TABLE 576 OTSUKA HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 577 OTSUKA HOLDINGS CO., LTD.: PRODUCT LAUNCHES
  • TABLE 578 OTSUKA HOLDINGS CO., LTD.: EXPANSIONS
  • TABLE 579 PHARMACARE LABORATORIES: COMPANY OVERVIEW
  • TABLE 580 PHARMACARE LABORATORIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 581 PHARMACARE LABORATORIES: EXPANSIONS
  • TABLE 582 SWANSON: COMPANY OVERVIEW
  • TABLE 583 SWANSON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 584 SWANSON: PRODUCT LAUNCHES
  • TABLE 585 IM HEALTHCARE: COMPANY OVERVIEW
  • TABLE 586 IM HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 587 SMP NUTRA: COMPANY OVERVIEW
  • TABLE 588 SMP NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 589 NATURE'S TRUTH: COMPANY OVERVIEW
  • TABLE 590 NATURE'S TRUTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 591 NATURE'S TRUTH: OTHER DEVELOPMENTS
  • TABLE 592 HERBALAND NATURALS INC.: COMPANY OVERVIEW
  • TABLE 593 HERBALAND NATURALS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 594 BOSCOGEN, INC.: COMPANY OVERVIEW
  • TABLE 595 BOSCOGEN, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 596 SOFGEN PHARMA: COMPANY OVERVIEW
  • TABLE 597 SOFGEN PHARMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 598 SOFGEN PHARMA: EXPANSIONS
  • TABLE 599 CATALENT, INC.: COMPANY OVERVIEW
  • TABLE 600 CATALENT, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 601 CATALENT, INC.: DEALS
  • TABLE 602 ACTIV'INSIDE: COMPANY OVERVIEW
  • TABLE 603 ACTIV'INSIDE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 604 SIRIO PHARMA CO., LTD.: COMPANY OVERVIEW
  • TABLE 605 SIRIO PHARMA CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 606 SIRIO PHARMA CO., LTD.: PRODUCT LAUNCHES
  • TABLE 607 WIN NUTRA: COMPANY OVERVIEW
  • TABLE 608 WIN NUTRA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 609 MAKERS NUTRITION, LLC.: COMPANY OVERVIEW
  • TABLE 610 MAKERS NUTRITION, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 611 ION LABS: COMPANY OVERVIEW
  • TABLE 612 ION LABS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 613 ION LABS: EXPANSIONS
  • TABLE 614 ION LABS: DEALS
  • TABLE 615 VITAJOY GROUP: COMPANY OVERVIEW
  • TABLE 616 VITAJOY GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 617 BLISS LIFESCIENCES LLP: COMPANY OVERVIEW
  • TABLE 618 BLISS LIFESCIENCES LLP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 619 GLOBAL WIDGET: COMPANY OVERVIEW
  • TABLE 620 GLOBAL WIDGET: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 621 GLOBAL WIDGET: PRODUCT LAUNCHES
  • TABLE 622 GLOBAL WIDGET: DEALS
  • TABLE 623 GLOBAL WIDGET: EXPANSIONS
  • TABLE 624 ADJACENT MARKETS TO NUTRACEUTICAL GUMMIES MARKET
  • TABLE 625 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 626 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 627 DIETARY SUPPLEMENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 628 DIETARY SUPPLEMENTS MARKET, BY REGION, 2024-2029 (USD MILLION)

List of Figures

  • FIGURE 1 NUTRACEUTICAL GUMMIES MARKET SEGMENTATION
  • FIGURE 2 YEARS CONSIDERED
  • FIGURE 3 MARKET SCENARIO
  • FIGURE 4 B2C NUTRACEUTICAL GUMMIES MARKET, 2021-2030
  • FIGURE 5 B2B NUTRACEUTICAL GUMMIES MARKET, 2021-2030
  • FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN B2C NUTRACEUTICAL GUMMIES MARKET (2020-2025)
  • FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 8 HIGH-GROWTH SEGMENTS IN B2C NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN B2C NUTRACEUTICAL GUMMIES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
  • FIGURE 10 FOCUS ON CONTRACT MANUFACTURING, SCALE EFFICIENCY, AND INGREDIENT AVAILABILITY TO DRIVE B2B NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 11 RISING CONSUMER PREFERENCE FOR CONVENIENT, FUNCTIONAL, AND PALATABLE SUPPLEMENTS TO DRIVE B2C NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 12 MID-SCALE MANUFACTURERS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025
  • FIGURE 13 VITAMINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025
  • FIGURE 14 BRAND OWNERS & MARKETING COMPANIES SEGMENT TO DOMINATE MARKET IN 2025
  • FIGURE 15 ANIMAL-BASED SOURCES SEGMENT TO LEAD MARKET IN 2025
  • FIGURE 16 GENERATION Z SEGMENT TO LEAD MARKET IN 2025
  • FIGURE 17 US TO DOMINATE MARKET IN 2025
  • FIGURE 18 US TO DOMINATE MARKET IN 2025
  • FIGURE 19 NUTRACEUTICAL GUMMIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 NUTRACEUTICAL GUMMIES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 21 NUTRACEUTICAL GUMMIES (B2B & B2C) MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 NUTRACEUTICAL GUMMIES MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 AVERAGE SELLING PRICE OF MARKET PLAYERS, BY PRODUCT TYPES, 2024 (USD/TON)
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF NUTRACEUTICAL GUMMIES, BY REGION, 2021-2024 (USD/TON)
  • FIGURE 25 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
  • FIGURE 26 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
  • FIGURE 27 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
  • FIGURE 28 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 29 NUMBER OF PATENTS GRANTED BETWEEN 2015 AND 2025
  • FIGURE 30 FUTURE APPLICATIONS
  • FIGURE 31 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 32 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
  • FIGURE 33 NUTRACEUTICAL GUMMIES MARKET DECISION-MAKING FACTORS
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP PRODUCT TYPES
  • FIGURE 35 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • FIGURE 36 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 37 NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 38 NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 39 NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 40 NUTRACEUTICAL GUMMIES MARKET, BY GUMMY BASE/EXCIPIENTS, 2025 VS. 2030 (USD MILLION)
  • FIGURE 48 REVENUE ANALYSIS OF B2C MARKET PLAYERS, 2022-2024 (USD MILLION)
  • FIGURE 49 SHARE ANALYSIS FOR B2C MARKET PLAYERS, 2024
  • FIGURE 50 SHARE ANALYSIS FOR B2B MARKET PLAYERS, 2024
  • FIGURE 51 NUTRACEUTICAL GUMMIES MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 52 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2C COMPANIES), 2024
  • FIGURE 53 B2C NUTRACEUTICAL GUMMIES MARKET: COMPANY FOOTPRINT
  • FIGURE 54 NUTRACEUTICAL GUMMIES MARKET: COMPANY EVALUATION MATRIX (B2B COMPANIES), 2024
  • FIGURE 55 COMPANY VALUATION FOR MAJOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET
  • FIGURE 56 EV/EBITDA OF MAJOR PLAYERS
  • FIGURE 57 CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT
  • FIGURE 58 H&H GROUP: COMPANY SNAPSHOT
  • FIGURE 59 AMWAY: COMPANY SNAPSHOT
  • FIGURE 60 BAYER AG: COMPANY SNAPSHOT
  • FIGURE 61 HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT
  • FIGURE 62 NESTLE: COMPANY SNAPSHOT
  • FIGURE 63 UNILEVER: COMPANY SNAPSHOT
  • FIGURE 64 OTSUKA HOLDINGS CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 65 SOFGEN PHARMA: COMPANY SNAPSHOT
  • FIGURE 66 SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 67 NUTRACEUTICAL GUMMIES MARKET: RESEARCH DESIGN
  • FIGURE 68 KEY INDUSTRY INSIGHTS
  • FIGURE 69 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
  • FIGURE 70 SUPPLY-SIDE ANALYSIS
  • FIGURE 71 DEMAND-SIDE ANALYSIS
  • FIGURE 72 B2C NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 73 B2B NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 74 NUTRACEUTICAL GUMMIES MARKET SHARE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 75 DATA TRIANGULATION METHODOLOGY
  • FIGURE 76 ASSUMPTIONS
  • FIGURE 77 STUDY LIMITATIONS AND RISK ASSESSMENT
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!